Mary G. George

Mary G. George

Auto-generated profile, based on publicly available information

Mary G. George

From the Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, GA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2022 in Neurology
Verified
Journal Article
Closed access
PDF file
QYQuanhe Yang
Quanhe Yang
XTXin Tong
Xin Tong
MGMary G. George
Mary G. George
ACAnping Chang
Anping Chang
RMRobert K. Merritt
Robert K. Merritt
Background and Objectives Findings of association between coronavirus disease 2019 (COVID-19) and stroke remain inconsistent, ranging from significant association to absence of association to less than expected ischemic stroke among hospitalized patients with COVID-19. The current study examined the association between COVID-19 and risk of acute ischemic stroke (AIS). Methods We included 37,379 Medicare fee-for-service (FFS) beneficiaries aged ≥65 years diagnosed with COVID-19 from April 1, 2020, through February 28, 2021, and AIS hospitalization from January 1, 2019, through February 28, 2021. We used a self-controlled case series design to examine the association between COVID-19 and AIS and estimated the incidence rate ratios (IRRs) by comparing incidence of AIS in risk periods (0–3, 4–7, 8–14, 15–28 days after diagnosis of COVID-19) vs control periods. Results Among 37,379 Medicare FFS beneficiaries with COVID-19 and AIS, the median age at diagnosis of COVID-19 was 80.4 (interquartile range 73.5–87.1) years and 56.7% were women. When AIS at day of exposure (day = 0) was included in the risk periods, IRRs at 0–3, 4–7, 8–14, and 15–28 days following COVID-19 diagnosis were 10.3 (95% confidence interval 9.86–10.8), 1.61 (1.44–1.80), 1.44 (1.32–1.57), and 1.09 (1.02–1.18); when AIS at day 0 was excluded in the risk periods, the corresponding IRRs were 1.77 (1.57–2.01) (day 1–3), 1.60 (1.43–1.79), 1.43 (1.31–1.56), and 1.09 (1.01–1.17), respectively. The association appeared to be stronger among younger beneficiaries and among beneficiaries without prior history of stroke but largely consistent across sex and race/ethnicities. Discussion Risk of AIS among Medicare FFS beneficiaries was 10 times (day 0 cases in the risk period) as high during the first 3 days after diagnosis of COVID-19 as during the control period and the risk associated with COVID-19 appeared to be stronger among those aged 65–74 years and those without prior history of stroke. Classification of Evidence This study provides Class IV evidence that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with increased risk of AIS in the first 3 days after diagnosis in Medicare FFS beneficiaries ≥65 years of age.

1 October 2014 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
GAGanesh Asaithambi
Ganesh Asaithambi
XTXin Tong
Xin Tong
MGMary G. George
Mary G. George
ATAlbert W. Tsai
Albert W. Tsai
JPJames M. Peacock
James M. Peacock
KLKamakshi Lakshminarayan
Kamakshi Lakshminarayan

1 May 2021 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
GAGanesh Asaithambi
Ganesh Asaithambi
XTXin Tong
Xin Tong
KLKamakshi Lakshminarayan
Kamakshi Lakshminarayan
SKSallyann M Coleman King
Sallyann M Coleman King
MGMary G George
Mary G George

17 August 2021 in Cerebrovascular Diseases
Verified
Journal Article
Open access
PDF file
GAGanesh Asaithambi
Ganesh Asaithambi
XTXin Tong
Xin Tong
SKSallyann M. Coleman King
Sallyann M. Coleman King
MGMary G. George
Mary G. George
Background: Presentation with mild symptoms is a common reason for intravenous thrombolysis (IVT) nonuse among acute ischemic stroke (AIS) patients. We examined the impact of IVT on the outcomes of mild AIS over time. Methods: Using the Paul Coverdell National Stroke Program data, we examined trends in IVT utilization from 2010 to 2019 among AIS patients presenting with National Institutes of Health Stroke Scale (NIHSS) scores ≤5. Outcomes adjudicated included rates of discharge to home and ability to ambulate independently at discharge. We used generalized estimating equation models to examine the effect of IVT on outcomes of AIS patients presenting with mild symptoms and calculated adjusted odds ratio (AOR) with 95% confidence intervals (CI). Results: During the study period, 346,762 patients presented with mild AIS symptoms. Approximately 6.2% were treated with IVT. IVT utilization trends increased from 3.7% in 2010 to 7.7% in 2019 (p < 0.001). Patients treated with IVT had higher median NIHSS scores upon presentation (IVT 3 [2, 4] vs. no IVT 2 [0, 3]). Rates of discharge to home (AOR 2.06, 95% CI: 1.99–2.13) and ability to ambulate at time of discharge (AOR 1.82, 95% CI: 1.76–1.89) were higher among those treated with IVT. Conclusion: There was an increased trend in IVT utilization among AIS patients presenting with mild symptoms. Utilization of IVT increased the odds of being discharged to home and the ability to ambulate at discharge independently in patients with mild stroke.